Crispr Therapeutics AG Financial Overview
Crispr Therapeutics AG's market cap is currently $5.33B. The company's EPS TTM is $-1.17; its P/E ratio is -9.81; Crispr Therapeutics AG is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-1.18. See an overview of income statement, balance sheet, and cash flow financials.
